Ligation of β4 integrins activates PKB/Akt and ERK1/2 by distinct pathways-relevance of the keratin filament

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 8, 2010, Pages 940-950

  Kippenberger, Stefan ^a   Hofmann, Matthias ^a   Zöller, Nadja ^a   Thaçi, Diamant ^a   Müller, Jutta ^a   Kaufmann, Roland ^a   Bernd, August ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Carcinogenesis; Epidermolysis bullosa; Hemidesmosome; Integrin; Keratin; Signalling

Indexed keywords

BETA4 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; KERATIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; PROTEIN SHC; RAF PROTEIN; RAS PROTEIN; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 3; MORPHOLINE DERIVATIVE; PROTEIN KINASE INHIBITOR; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EPIDERMOLYSIS BULLOSA SIMPLEX; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; EPITHELIUM CELL; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANDROSTADIENES; ANIMALS; CELL LINE; CHROMONES; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; INTEGRIN BETA4; KERATINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 77953706944     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.03.009     Document Type: Article

References (66)

1. Watt F.M. Terminal differentiation of epidermal keratinocytes. Curr. Opin. Cell Biol. 1989, 1:1107-1115.
2. Watt F.M. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 2002, 21:3919-3926.
3. Adams J.C., Watt F.M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 1989, 340:307-309.
4. Levy L., Broad S., Diekmann D., Evans R.D., Watt F.M. beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol. Biol. Cell 2000, 11:453-466.
5. Aumailley M., Rousselle P. Laminins of the dermo-epidermal junction. Matrix Biol. 1999, 18:19-28.
6. Wiche G., Gromov D., Donovan A., Castanon M.J., Fuchs E. Expression of plectin mutant cDNA in cultured cells indicates a role of COOH-terminal domain in intermediate filament association. J. Cell Biol. 1993, 121:607-619.
7. Yang Y., Dowling J., Yu Q.C., Kouklis P., Cleveland D.W., Fuchs E. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 1996, 86:655-665.
8. Rabinovitz I., Toker A., Mercurio A.M. Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J. Cell Biol. 1999, 146:1147-1160.
9. Svitkina T.M., Verkhovsky A.B., Borisy G.G. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J. Cell Biol. 1996, 135:991-1007.
10. Shaw L.M., Rabinovitz I., Wang H.H., Toker A., Mercurio A.M. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 1997, 91:949-960.
11. Mercurio A.M., Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin. Cancer Biol. 2001, 11:129-141.
12. Borradori L., Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J. Invest. Dermatol. 1999, 112:411-418.
13. Tennenbaum T., Weiner A.K., Belanger A.J., Glick A.B., Hennings H., Yuspa S.H. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 1993, 53:4803-4810.
14. Grossman H.B., Lee C., Bromberg J., Liebert M. Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer. Oncol. Rep. 2000, 7:13-16.
15. Tani T., Karttunen T., Kiviluoto T., Kivilaakso E., Burgeson R.E., Sipponen P., Virtanen I. Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: implications for acquisition of the invading phenotype. Am. J. Pathol. 1996, 149:781-793.
16. Bon G., Folgiero V., Bossi G., Felicioni L., Marchetti A., Sacchi A., Falcioni R. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. Clin. Cancer Res. 2006, 12:3280-3287.
17. Lipscomb E.A., Simpson K.J., Lyle S.R., Ring J.E., Dugan A.S., Mercurio A.M. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res. 2005, 65:10970-10976.
18. Tang K., Nie D., Cai Y., Honn K.V. The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signaling pathway. Biochem. Biophys. Res. Commun. 1999, 264:127-132.
19. Trusolino L., Bertotti A., Comoglio P.M. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 2001, 107:643-654.
20. Kippenberger S., Loitsch S., Müller J., Guschel M., Kaufmann R., Bernd A. Ligation of the beta4 integrin triggers adhesion behavior of human keratinocytes by an "inside-out" mechanism. J. Invest. Dermatol. 2004, 123:444-451.
21. Bellacosa A., de Feo D., Godwin A.K., Bell D.W., Cheng J.Q., Altomare D.A., Wan Test M. article sample title placed here. Int. J. Cancer 1995, 64:280-285.
22. Cheng J.Q., Ruggeri B., Klein W.M., Sonoda G., Altomare D.A., Watson D.K., Testa JR J.R. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3636-3641.
23. Miwa W., Yasuda J., Murakami Y., Yashima K., Sugano K., Sekine T., Kono A., Egawa S., Yamaguchi K., Hayashizaki Y., Sekiya T. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem. Biophys. Res. Commun. 1996, 225:968-974.
24. Ruggeri B.A., Huang L., Wood M., Cheng J.Q., Testa J.R. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol. Carcinog. 1998, 21:81-86.
25. Dans M., Gagnoux-Palacios L., Blaikie P., Klein S., Mariotti A., Giancotti F.G. Tyrosine phosphorylation of the beta 4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes. J. Biol. Chem. 2001, 276:1494-1502.
26. Nikolopoulos S.N., Blaikie P., Yoshioka T., Guo W., Puri C., Tacchetti C., Giancotti F.G. Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol. Cell. Biol. 2005, 25:6090-6102.
27. Kohno M., Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 2006, 38:200-211.
28. Eckert B.S., Yeagle P.L. Modulation of keratin intermediate filament distribution in vivo by induced changes in cyclic AMP-dependent phosphorylation. Cell Motil. Cytoskelet. 1990, 17:291-300.
29. Morley S.M., D'Alessandro M., Sexton C., Rugg E.L., Navsaria H., Shemanko C.S., Huber M., Hohl D., Heagerty A.I., Leigh I.M., Lane E.B. Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br. J. Dermatol. 2003, 149:46-58.
30. Russell D., Andrews P.D., James J., Lane E.B. Mechanical stress induces profound remodelling of keratin filaments and cell junctions in epidermolysis bullosa simplex keratinocytes. J. Cell Sci. 2004, 117:5233-5243.
31. Bao J., Alroy I., Waterman H., Schejter E.D., Brodie C., Gruenberg J., Yarden Y. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J. Biol. Chem. 2000, 275:26178-26186.
32. Zhang S., Han J., Sells M.A., Chernoff J., Knaus U.G., Ulevitch R.J., Bokoch G.M. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 1995, 270:23934-23936.
33. Mettouchi A., Klein S., Guo W., Lopez-Lago M., Lemichez E., Westwick J.K., Giancotti F.G. Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle. Mol. Cell 2001, 8:115-127.
34. Shaw L.M., Chao C., Wewer U.M., Mercurio A.M. Function of the integrin alpha 6 beta 1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor. Cancer Res. 1996, 56:959-963.
35. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376:599-602.
36. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81:727-736.
37. Kohn A.D., Kovacina K.S., Roth R.A. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 1995, 14:4288-4295.
38. Thomas S.M., DeMarco M., D'Arcangelo G., Halegoua S., Brugge J.S. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 1992, 68:1031-1040.
39. Rozakis-Adcock M., Fernley R., Wade J., Pawson T., Bowtell D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 1993, 363:83-85.
40. Di Guglielmo G.M., Baass P.C., Ou W.J., Posner B.I., Bergeron J.J. Compartmentalization of Shc, Grb2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 1994, 13:4269-4277.
41. Aspenström P. The Rho GTPases have multiple effects on the actin cytoskeleton. Exp. Cell Res. 1999, 246:20-25.
42. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15:6541-6551.
43. Lane E.B., Rugg E.L., Navsaria H., Leigh I.M., Heagerty A.H., Ishida-Yamamoto A., Eady R.A. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992, 356:244-246.
44. Paramio J.M., Jorcano J.L. Beyond structure: do intermediate filaments modulate cell signalling?. Bioessays 2002, 24:836-844.
45. Vijayaraj P., Kröger C., Reuter U., Windoffer R., Leube R.E., Magin T.M. Keratins regulate protein biosynthesis through localization of GLUT1 and -3 upstream of AMP kinase and Raptor. J. Cell Biol. 2009, 187:175-184.
46. Chu Y.W., Seftor E.A., Romer L.H., Hendrix M.J. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am. J. Pathol. 1996, 148:63-69.
47. Song G., Ouyang G., Bao S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 2005, 9:59-71.
48. Santos M., Paramio J.M., Bravo A., Ramirez A., Jorcano J.L. The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis. J. Biol. Chem. 2002, 277:19122-19130.
49. Bonfini L., Migliaccio E., Pelicci G., Lanfrancone L., Pelicci P.G. Not all Shc's roads lead to Ras. Trends Biochem. Sci. 1996, 21:257-261.
50. Xu Y., Carpenter G. Identification of cadherin tyrosine residues that are phosphorylated and mediate Shc association. J. Cell. Biochem. 1999, 75:264-271.
51. Segatto O., Pelicci G., Giuli S., Digiesi G., Di Fiore P.P., McGlade J., Pawson T., Pelicci P.G. Shc products are substrates of erbB-2 kinase. Oncogene 1993, 8:2105-2112.
52. Piiper A., Elez R., You S.J., Kronenberger B., Loitsch S., Roche S., Zeuzem S. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon. J. Biol. Chem. 2003, 278:7065-7072.
53. Rubio I., Rennert K., Wittig U., Wetzker R. Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor. Biochem. J. 2003, 376:571-576.
54. Kippenberger S., Loitsch S., Guschel M., Müller J., Knies Y., Kaufmann R., Bernd A. Mechanical stretch stimulates protein kinase B/Akt phosphorylation in epidermal cells via angiotensin II type 1 receptor and epidermal growth factor receptor. J. Biol. Chem. 2005, 280:3060-3067.
55. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
56. Moro L., Venturino M., Bozzo C., Silengo L., Altruda F., Beguinot L., Tarone G., Defilippi P. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 1998, 17:6622-6632.
57. Prenzel N., Zwick E., Leserer M., Ullrich A. Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification. Breast Cancer Res. 2002, 2:184-190.
58. Bill H.M., Knudsen B., Moores S.L., Muthuswamy S.K., Rao V.R., Brugge J.S., Miranti C.K. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol. Cell. Biol. 2004, 24:8586-8599.
59. Klemke R.L., Yebra M., Bayna E.M., Cheresh D.A. Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin. J. Cell Biol. 1994, 127:859-866.
60. Mainiero F., Pepe A., Yeon M., Ren Y., Giancotti F.G. The intracellular functions of alpha6beta4 integrin are regulated by EGF. J. Cell Biol. 1996, 134:241-253.
61. Trusolino L., Serini G., Cecchini G., Besati C., Ambesi-Impiombato F.S., Marchisio P.C., De Filippi R. Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion. J. Cell Biol. 1998, 142:1145-1156.
62. Fischer O.M., Hart S., Gschwind A., Ullrich A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 2003, 31:1203-1208.
63. Sahai E., Marshall C.J. Rho-GTPases and cancer. Nat. Rev., Cancer 2002, 2:133-142.
64. Fritz G., Kaina B. Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006, 6:1-14.
65. Li W., Chong H., Guan K.L. Function of the Rho family GTPases in Ras-stimulated Raf activation. J. Biol. Chem. 2001, 276:34728-34737.
66. Arai A., Kanda E., Miura O. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Oncogene 2002, 21:2641-2651.